Skip to main content

Advertisement

Table 3 Base case results representing an annual cohort from England (secondary outcomes)

From: A model-based assessment of the cost–utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients

Strategy 1(2) 2 3 4 5 6 7 8
Number of colonoscopies vs Strategy 1(1) (=4162) +1618 +3044 +3008 +3401 +3381 +3381 +3842 +4400
Life expectancy of index patient vs Strategy 1(1) (=13.82 years) +0.06 +0.10 +0.10 +0.12 +0.12 +0.12 +0.13 +0.14
Life expectancy of index patient with LS vs Strategy 1(1) (=12.93 years) +0.72 +1.24 +1.24 +1.39 +1.39 +1.39 +1.56 +1.61
Life expectancy of relative vs Strategy 1(1) (=37.38 years) +0.01 +0.05 +0.05 +0.05 +0.05 +0.05 +0.06 +0.06
Life expectancy of relative with LS vs Strategy 1(1) (=33.97 years) +0.31 +1.24 +1.24 +1.39 +1.39 +1.39 +1.56 +1.61
Expected number of CRCs vs Strategy 1(1) (=664.9) −8.36 −24.59 −24.56 −27.59 −27.57 −27.57 −30.95 −32.30
Expected number of ECs vs Strategy 1(1) (=53.8) −4.99 −14.29 −14.29 −16.03 −16.03 −16.03 −17.97 −18.55
  1. Abbreviations: EC endometrial cancer.